LONDON, June 27, 2014 /PRNewswire/ --

Today, Earnings Review released its analysts' notes regarding Hikma Pharmaceuticals Plc (LON: HIK), Rathbone Brothers Plc (LON: RAT), Rotork Plc (LON: ROR), Bank of Georgia Holdings Plc (LON: BGEO) and Coca Cola HBC AG (LON: CCH). Private wealth members receive these notes ahead of publication. To reserve complementary membership, limited openings are available at: http://earnings-review.com/4214-100free.

Hikma Pharmaceuticals Plc Analyst Notes
As per the financial calendar on the website of Hikma Pharmaceuticals Plc (Hikma), the Company will observe closed period from July 1, 2014, ahead of the announcement of H1 2014 interim results on August 20, 2014. Hikma recently announced asset purchase agreement with Ben Venue Laboratories, Inc., a member of the Boehringer Ingelheim Group of Companies, to acquire assets of Bedford Laboratories ("Bedford"), its US generic injectables business, for a total consideration of up to $300 million. In 2013, Hikma's global Injectables business generated revenue of $536 million and accounted for 39% of Group revenue. The full analyst notes on Hikma are available to download free of charge at:

http://earnings-review.com/4214-HIK-27Jun2014.pdf

Rathbone Brothers Plc Analyst Notes
On June 9, 2014, Rathbone Brothers Plc (Rathbones) announced that Rathbone Investment Management Ltd has received full Global Investment Performance Standards (GIPS) accreditation. According to Rathbones, GIPS is the highest independent indicator of investment performance reporting and is created and maintained by the Chartered Financial Analyst (CFA) Institute. Paul Chavasse, Head -Investment Management, Rathbones, said, "The confirmation of our full GIPS compliance is also testament to the infrastructure of systems, processes and controls we have put in place and in which we have made significant investment over recent years." The full analyst notes on Rathbone are available to download free of charge at:

http://earnings-review.com/4214-RAT-27Jun2014.pdf

Rotork Plc Analyst Notes
On June 10, 2014, Rotork Plc (Rotork) announced that the entire Shan-Jing gas pipeline network will be operated with Rotork IQ intelligent electric actuators, after the Company's new IQ actuators will replace a competitor's actuators already installed on the first pipeline. Rotork said that the work will be completed by the end of 2014. Shan-Jing gas pipeline, one of China's key national projects, supplying natural gas from the western province of Shaanxi to the capital city of Beijing, has already deployed Rotork's actuators on the second and third pipeline. The full analyst notes on Rotork are available to download free of charge at:

http://earnings-review.com/4214-ROR-27Jun2014.pdf

Bank of Georgia Holdings Plc Analyst Notes
On June 12, 2014, Bank of Georgia Holdings Plc (Bank of Georgia) announced that its real estate subsidiary JSC m2 Real Estate has completed construction of its largest project till date. The Bank informed that the project comprising 522 residential apartments with a total buildable area of 63,247 square metres has been completed four months ahead of schedule. Irakli Gilauri, CEO, Bank of Georgia, said, "I would like to congratulate the Investment Management team for successfully placing the issuance. The team demonstrated its significant placement power by building the book in less than three hours. The demand was primarily driven by international and local wealth management clients. I am also pleased that we have offered high yielding product to our wealth management clients on the back of deposit rate cuts. The yield on m2 bonds is significantly higher than the deposit rates currently offered on the market." The full analyst notes on Bank of Georgia are available to download free of charge at:

http://earnings-review.com/4214-BGEO-27Jun2014.pdf

Coca Cola HBC AG Analyst Notes
On June 12, 2014, Coca Cola HBC AG (Coca Cola) notified the transactions of directors/persons discharging managerial responsibility (PDMR) and connected persons. The Company informed that Dan Iulian Timotin (PDMR) acquired 720 ordinary shares at a price per share of £13.89 on June 11, 2014 at London Stock Exchange. The full analyst notes on Coca Cola HBC are available to download free of charge at:

http://earnings-review.com/4214-CCH-27Jun2014.pdf

===============
EDITOR'S NOTES:
===============

1. This is not company news. We are an independent source and our views do not reflect the companies mentioned.

2. Information in this release is produced on a best efforts basis by Rohit Tuli, a CFA charterholder. The content is then further fact checked and reviewed by an outsourced research provider. However, we are only human and are prone to make mistakes. If you notice any errors or omissions, please notify us below.

3. This information is submitted as a net-positive to companies mentioned, to increase awareness for mentioned companies to our subscriber base and the investing public.

4. If you wish to have your company covered in more detail by our team, or wish to learn more about our services, please contact us at pubco [at] http://earnings-review.com.

5. For any urgent concerns or inquiries, please contact us at compliance [at] http://earnings-review.com.

6. Are you a public company? Would you like to see similar coverage on your company? Send us a full investors' package to research [at] http://earnings-review.com for consideration.

COMPLIANCE PROCEDURE
Content is researched, written and reviewed on a best-effort basis. This document, article or report is prepared and authored by Earnings Review, represented by Rohit Tuli, CFA. An outsourced research services provider has only reviewed the information provided by Earnings Review in this article or report according to the procedures outlined by Earnings Review. Earnings Review is not entitled to veto or interfere in the application of such procedures by the outsourced provider to the articles, documents or reports, as the case may be.

NOT FINANCIAL ADVICE
Earnings Review makes no warranty, expressed or implied, as to the accuracy or completeness or fitness for a purpose (investment or otherwise), of the information provided in this document. This information is not to be construed as personal financial advice. Readers are encouraged to consult their personal financial advisor before making any decisions to buy, sell or hold any securities mentioned herein.

NO WARRANTY OR LIABILITY ASSUMED
Earnings Review is not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted by Earnings Review whatsoever for any direct, indirect or consequential loss arising from the use of this document. Earnings Review expressly disclaims any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Earnings Review does not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

http://earnings-review.com

SOURCE Earnings Review